Patients with Friedreich’s Ataxia Show Improvements with Investigational EPI-743 - Research, Science, and Trials - Friedreich's Ataxia News Forums

Research, Science, and Trials

Patients with Friedreich’s Ataxia Show Improvements with Investigational EPI-743

Posted by FA Forums Moderator on February 21, 2019 at 8:12 am

Long-term use of EPI-743 (vatiquinone) can improve neurological function and prevent progression of Friedreich’s ataxia, Phase 2 trial results show. Read more about this trial and its findings here.

What are your thoughts about this news?

Deleted User replied 5 years, 2 months ago 2 Members · 1 Reply
1 Reply

Deleted User

Deleted User
February 21, 2019 at 1:16 pm

Good news! I commend all of the hard working doctors and everyone involved in curing FA

Log In to Reply

Log in to reply.